Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B (MAO-B). Rasagiline demonstrates complete and selective ...
News Medical on MSN7d
Bioactive compounds in coffee and tobacco may combat Parkinson’s diseaseTobacco and coffee contain bioactive compounds that may reduce Parkinson's disease risk by targeting key pathways such as MAO ...
Verywell Health on MSN3mon
Common Medications for Parkinson’s DiseaseHealthcare providers may prescribe levodopa, dopamine agonists, anticholinergics, catechol-o-methyltransferase (COMT) ...
a MAO-B = monoamine oxidase type B, MAO-A = monoamine oxidase type A. b Expressed as the molar concentration of drug required to inhibit enzyme activity by 50% (nmol/L). c Expressed as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback